Stanford University
PhD, Genetics
2016 - 2023
Vanderbilt University
BA, Molecular and Cellular Biology
2007 - 2011
Global Segment Lead, Cancer Genomics, PacBio
2023 - present
Developed and implemented global marketing strategy for the cancer genomics segment, leading to strong YoY segment revenue growth.
Identified and led strategic academic and commercial collaborations with KOLs to generate evidence and share results demonstrating PacBio's value prop for cancer genomics applications.
Acted as subject matter expert on liquid biopsy and cancer genomics in external meetings with customers and partners, as well as internally to executives and the commercial and R&D teams.
Informed product strategy by identifying critical product development needs for segment and company growth, quantifying potential market impact, and pitching to executive team.
Pharma and Biotech Consultant, Collective Acumen
2020 - 2023
Worked directly with principals, consultants, and analysts to address strategic needs for pharmaceutical and biotechnology clients.
Researched and summarized the pathophysiology, diagnostic workup, and treatment practices across a variety of disease states.
Investigated the market landscape and competitive dynamics using both public and private data sources.
Assisted in the development and execution of market research projects, including the design of tools for data collection and statistical analysis of market data.
Synthesized market research and analysis to extract relevant strategic insights for clients.
Developed programming and delivered presentations to communicate insights during internal and client-facing meetings.
Communicated strategic insights through the design and execution of client-facing presentations.
Investment Analyst, Mythos Biotechnology Fund
2020 - 2023
General partnership made up of Stanford PhD students and postdocs which invests in publicly-traded biotechnology and pharmaceutical companies
Worked on a small team of investment analysts to identify compelling market opportunities and perform diligence
PhD Candidate, Stanford University, Department of Genetics
2016 - 2023
Advisors: Christina Curtis and Polly Fordyce
Developed novel microwell platform for high-throughput phenotyping of cancer organoids and discovered changes in growth rate and cellular polarity in a model of early tumor evolution.
Implemented method linking single-cell genotype to phenotype via spectrally encoded beads.
Created novel expressed cellular barcode system for linking lineage information to single-cell transcriptomes.
Initiated a new collaboration between Christina Curtis, Polly Fordyce, and Calvin Kuo on organoid models of cancer evolution.
Lab Manager, Stanford University, Department of Genetics
2012-2016
Advisor: Carlos Bustamante
Responsible for project management, wet lab experimentation, new student mentoring, grant and status report preparation, and financial tracking for all projects in our 25 person lab
Projects include development of a non-biased strategy for genotyping in diverse populations, validation of exome sequencing using saliva DNA, creation of a phylogenetic tree for human populations using targeted sequencing of Y chromosomes, application of capture methods for preeclampsia and pigmentation, and development of a platform for CFTR variant pathogenicity assessment.
Managed in-house NextSeq 500 sequencer, including financial tracking and projections
Project Manager, Stanford University, Department of Genetics
2012
Advisor: Carlos Bustamante
Coordinated cacao sequencing project including coordination with collaborators, delegation of tasks, and development and implementation of a timeline for completion in collaboration with industry partner Mars, Inc.
Responsible for running meetings, project planning, organizing international shipment of samples, and all wet lab experimentation to sequence several hundred cacao samples.
Research Assistant, Vanderbilt University, Department of Pulmonology
2012
Advisor: Timothy Blackwell
Responsible for sample collection and processing, cell culture and DNA extraction, and targeted sequencing of candidate genes and analysis of sequencing results for project to uncover the genetic basis of idiopathic pulmonary fibrosis (IPF)
Performed sequencing of entire families to discover early molecular markers for IPF to supplement traditional clinical markers
Research Assistant, Vanderbilt University, Department of Human Genetics
2011-2012
Advisor: Jeffrey Smith
Generated targeted genotyping data for breast and prostate cancer patients in Vanderbilt’s BioVU biobank
Responsible for sample processing, data analysis, and literature review of genes of interest
Business/Consulting: Market strategy, partnership management, solution selling, market sizing, competitive intelligence, go-to-market planning, pipeline/target prioritization, KOL interviews and surveys, NPV modeling, investment analysis
Technical/Lab: Next-generation sequencing, microfluidic device design and fabrication, mammalian 2D and 3D cell culture, CRISPR editing, basic molecular biology techniques (PCR, cloning, gel electrophoresis, Western/Southern blots, etc.)
Computational: Proficient in Python, R, Bash, Fiji/ImageJ, Adobe Illustrator, AutoCAD, and Office/GSuite
NSF Graduate Research Fellowship Program
2017-2020
National Merit Scholarship Winner
2007-2011
Phi Beta Kappa Essay Prize
2008
SBSA National Science Foundation Mentor
2018-2023
SSRP Research Mentor
2016-2023
SBSA First Year Mentor
2017-2023
Stanford Science Penpals
2016-2023
SBSA Social Co-Chair
2016
“METHOD TO PERFORM HIGH-THROUGHPUT SINGLE CELL GENOMIC AND PHENOTYPIC ANALYSES”
PCT/US2019/040139. Filed July 1, 2019
“ARRAY PLATFORM FOR HIGH-THROUGHPUT ORGANOID PROFILING”
Provisional patent filed October 4, 2022